Your browser doesn't support javascript.
loading
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC.
Kim, Hye Ryun; Awad, Mark M; Navarro, Alejandro; Gottfried, Maya; Peters, Solange; Csoszi, Tibor; Cheema, Parneet K; Rodriguez-Abreu, Delvys; Wollner, Mirjana; Yang, James Chih-Hsin; Mazieres, Julien; Orlandi, Francisco J; Luft, Alexander; Gümüs, Mahmut; Kato, Terufumi; Kalemkerian, Gregory P; Luo, Yiwen; Santorelli, Melissa L; Pietanza, M Catherine; Rudin, Charles M.
Afiliação
  • Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Navarro A; Clinical Research Department (VHIO) and Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Gottfried M; Oncology Department, Meir Medical Center, Kfar-Saba, Israel.
  • Peters S; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
  • Csoszi T; Department of Oncology, Hetenyi G Korhaz Onkologiai Kozpont, Szolnok, Hungary.
  • Cheema PK; Division of Medical Oncology, William Osler Health System, University of Toronto, Brampton, Ontario, Canada.
  • Rodriguez-Abreu D; Medical Oncology Department, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Wollner M; Department of Medical Oncology, Rambam Medical Center, Haifa, Israel.
  • Yang JC; Department of Oncology, National Taiwan University Hospital and Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Mazieres J; Department of Thoracic Oncology, Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France.
  • Orlandi FJ; Region Metropolitana de Santiago, Orlandi Oncologia, Santiago, Chile.
  • Luft A; Department of Oncology No. 1 (Thoracic Surgery), Leningrad Regional Clinical Hospital, St. Petersburg, Russia.
  • Gümüs M; Department of Medical Oncology, Istanbul Medeniyet University Hospital, Istanbul, Turkey.
  • Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Kalemkerian GP; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Luo Y; Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, New Jersey.
  • Santorelli ML; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, New Jersey.
  • Pietanza MC; Global Clinical Development, Merck & Co., Inc., Rahway, New Jersey.
  • Rudin CM; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
JTO Clin Res Rep ; 4(11): 100572, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37954964
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul